FDA allergy/redness relief eyedrops adverse event list includes 426 pupil dilation cases .
This article was originally published in The Tan Sheet
Executive Summary
VASOCONSTRICTOR PUPIL DILATION ADVERSE EVENT REPORTS TOTAL 426 from the first quarter of 1995 through the first quarter of 1997, according to spontaneous reporting system data compiled by the FDA Division of Pharmacovigilance & Epidemiology. The adverse drug experience reports were the basis for FDA's recent proposed OTC vasoconstrictor label statement cautioning against pupil dilation ("The Tan Sheet" March 2, p. 11).